Compare DRD & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRD | AXGN |
|---|---|---|
| Founded | 1895 | N/A |
| Country | South Africa | United States |
| Employees | 3410 | N/A |
| Industry | Precious Metals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | N/A | 2013 |
| Metric | DRD | AXGN |
|---|---|---|
| Price | $26.87 | $43.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $32.63 | ★ $42.33 |
| AVG Volume (30 Days) | 184.5K | ★ 1.1M |
| Earning Date | 08-19-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $39.23 | $20.57 |
| Revenue Next Year | $30.12 | $16.68 |
| P/E Ratio | $15.32 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $13.08 | $9.22 |
| 52 Week High | $39.37 | $45.83 |
| Indicator | DRD | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 35.57 | 72.70 |
| Support Level | $25.95 | $29.48 |
| Resistance Level | $32.74 | N/A |
| Average True Range (ATR) | 0.85 | 2.18 |
| MACD | -0.36 | 0.70 |
| Stochastic Oscillator | 3.70 | 81.05 |
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.